NYXH

Handel nachbörslich: 4.76

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1113)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Vergleichen Sie NYXH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	4.76	206.10M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	525.04	187.46B	10.06B	2.88B	2.27B	7.8807
BDX Becton Dickinson Co	203.40	57.96B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.87	39.68B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	46.31	37.32B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	255.50	37.29B	5.26B	1.44B	1.76B	9.7713

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Vergleichen Sie NYXH mit anderen Aktien

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru

Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn

Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review

Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com

Sleep apnea-focused Nyxoah to add Belgian plant as US demand grows - Stock Titan

Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com

Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn

(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView

NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets

Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛

Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - TipRanks

Nyxoah (NASDAQ: NYXH) reports preliminary 2025 results and Q1 2026 view - Stock Titan

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target By Investing.com - Investing.com South Africa

Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $12 - 富途资讯

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target - Investing.com Australia

Is Nyxoah SA stock a safe investment in uncertain markets2025 Growth vs Value & Verified Swing Trading Watchlist - Bộ Nội Vụ

Belgium-based Nyxoah’s net revenue expected to increase 348% in Q4 2025 - Medical Buyer

Nyxoah Shares Surge On Strong Q4 Preliminary Revenue - Nasdaq

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 - The Manila Times

News - FinancialContent

Nyxoah SA's (EBR:NYXH) market cap rose €19m last week; retail investors who hold 44% profited and so did insiders - simplywall.st

Publication relating to transparency notification - GlobeNewswire

Aug Opening: Is Nyxoah SA stock a contrarian buyJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Bộ Nội Vụ

Is Nyxoah SA stock a good choice for value investorsSeasonal Picks & what to check before ordering - Улправда

Is Nyxoah SA stock a contrarian buyMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда

How Nyxoah SA (5YI) stock benefits from digital adoptionPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru

Aug Intraday: Is Nyxoah SA stock a good choice for value investors2025 Technical Overview & Community Consensus Trade Alerts - Улправда

Why Nyxoah SA stock is recommended by analysts2025 Pullback Review & Safe Entry Momentum Stock Tips - ulpravda.ru

Nyxoah SA (NYXH) Stock Analysis: Exploring a Potential 125.84% Upside in the Healthcare Sector - DirectorsTalk Interviews

Nyxoah receives Medicare reimbursement increases for Genio - MSN

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

PRN_FinancialWrapper | PR NewswireNyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent

Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH) - Defense World

Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $5.87 - 富途牛牛

Nyxoah to Participate in Upcoming Investor Conferences - Macau Business

Nyxoah SA (NYXH) Stock Analysis: Exploring a 145.53% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews

Nyxoah announces commercial launch of Genio system in the Netherlands - MSN

Nyxoah launches Genio therapy in Netherlands and closes first €22.5 million tranche of convertible notes - MSN

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - Macau Business

Nyxoah Announces Issuance of First Tranche of Convertible Bonds - The Manila Times

Is Nyxoah SA stock positioned for digital transformationQuarterly Trade Review & Consistent Return Investment Signals - Улправда

Nyxoah Launches Genio Therapy in Netherlands and Closes First €22.5 Million Tranche of Convertible Notes - TipRanks

Earnings Recap: Is Nyxoah SA stock a good choice for value investorsJuly 2025 Highlights & Target Return Focused Picks - Bộ Nội Vụ

Can Nyxoah SA stock deliver strong Q4 earningsQuarterly Growth Report & Smart Swing Trading Alerts - DonanımHaber

Is Nyxoah SA (5YI) stock undervalued historicallyJuly 2025 Sentiment & Daily Profit Maximizing Tips - DonanımHaber

Sleep apnea device maker Nyxoah secures €22.5M to extend cash runway - Stock Titan

How Nyxoah SA stock performs in high volatility markets2025 Historical Comparison & Expert Curated Trade Setups - ulpravda.ru

Nyxoah Launches New OSA Therapy | Patient-Centric Breakthrough - Precedence Research

Nyxoah Launches Genio Neurostimulator System in the Netherlands - marketscreener.com

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH